Lp-PLA2-IN-13

Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodegenerative related diseases[1].

Product Specifications

CAS Number

[2756855-62-4]

UNSPSC

12352005

Target

Phospholipase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/lp-pla2-in-13.html

Purity

99.95

Solubility

10 mM in DMSO

Smiles

O=C1N=C(C2=C(N1CCC3)N3CCO2)OCC4=CC(F)=C(C(F)=C4)OC5=CC(C(F)(F)F)=NC=C5

Molecular Formula

C22H17F5N4O4

Molecular Weight

496.39

References & Citations

[1]ZhengHua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. CN113861220A.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-47899C 0.1 mL

Mouse Monoclonal Myosin heavy chain 11 Antibody (ID8) [DyLight 650]

Ask

View Details

GTR15251428 1 Vial

Lentiviral mouse Trmt9b shRNA (UAS) - Lentiviral mouse Trmt9b shRNA (UAS, iRFP) plasmid

Ask

View Details

TRC-P437833-500MG 500 mg

Pigment Green 7 (Technical Grade)

Ask

View Details

SC122104 10 µg

GJD2 (NM_020660) Human Untagged Clone

Ask

View Details

STJ72145 100 µg

Anti-PON2 antibody

Ask

View Details